Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Smartphone Cognitive Behavioral Therapy for Major Depressive Disorder: A Randomized, Waitlist-control Trial

NCT04594616 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT04594616
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04594616 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Smartphone Cognitive Behavioral Therapy for Major Depressive Disorder: A Randomized, Waitlist-control Trial
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Withdrawn
Start date
September 1, 2024
Completion date
December 1, 2027
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder